ANAND CHATURVEDI: Open Payments
NPI 1700857331 · FAIRLAWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$56,237 in 273 payments from 18 companies in 2025. Trend: 2023 $36,995 · 2024 $42,469 · 2025 $56,237
Speaker / faculty: $28,003Honoraria: $14,075Consulting: $6,310Food & beverage: $5,097Travel & lodging: $2,640Education: $111
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 22 | $15,970 |
| ABBVIE INC. | 39 | $12,947 |
| Otsuka America Pharmaceutical, Inc. | 33 | $12,052 |
| Alkermes, Inc. | 37 | $9,890 |
| E.R. Squibb & Sons, L.L.C. | 25 | $2,193 |
| Janssen Pharmaceuticals, Inc | 16 | $1,036 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $593 |
| Teva Pharmaceuticals USA, Inc. | 15 | $573 |
| Lundbeck LLC | 25 | $209 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $199 |
Products named: Auvelity, VRAYLAR, REXULTI, LYBALVI, SPRAVATO, CAPLYTA, ARISTADA, COBENFY.
Industry payments across OH — which companies pay providers there.
